Is 0QBM undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0QBM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0QBM (PLN90.29) is trading below our estimate of fair value (PLN307.34)
Significantly Below Fair Value: 0QBM is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0QBM?
Key metric: As 0QBM is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for 0QBM. This is calculated by dividing 0QBM's market cap by their current
earnings.
What is 0QBM's PE Ratio?
PE Ratio
4.9x
Earnings
zł2.42b
Market Cap
zł11.72b
0QBM key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: 0QBM is good value based on its Price-To-Earnings Ratio (4.9x) compared to the European Banks industry average (7.3x).
Price to Earnings Ratio vs Fair Ratio
What is 0QBM's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
0QBM PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
4.9x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 0QBM's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 0QBM forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
zł90.29
zł108.36
+20.0%
7.8%
zł124.00
zł96.70
n/a
8
Nov ’25
n/a
zł108.36
0%
7.8%
zł124.00
zł96.70
n/a
8
Oct ’25
n/a
zł108.74
0%
7.9%
zł124.00
zł96.70
n/a
8
Sep ’25
zł102.71
zł106.89
+4.1%
11.2%
zł124.00
zł81.90
n/a
8
Aug ’25
zł97.21
zł102.89
+5.8%
10.2%
zł115.00
zł81.90
n/a
8
Jul ’25
zł103.29
zł97.30
-5.8%
20.2%
zł115.00
zł52.91
n/a
8
Jun ’25
n/a
zł97.41
0%
20.1%
zł115.00
zł52.91
n/a
8
May ’25
n/a
zł90.04
0%
27.7%
zł115.00
zł50.00
n/a
8
Apr ’25
n/a
zł81.66
0%
25.3%
zł111.10
zł50.00
n/a
8
Mar ’25
n/a
zł73.13
0%
20.4%
zł94.00
zł50.00
n/a
9
Feb ’25
n/a
zł70.25
0%
18.6%
zł87.00
zł50.00
n/a
9
Jan ’25
n/a
zł66.33
0%
20.6%
zł87.00
zł43.00
n/a
9
Dec ’24
n/a
zł64.45
0%
25.0%
zł87.00
zł32.00
n/a
9
Nov ’24
n/a
zł60.69
0%
22.0%
zł81.00
zł32.00
n/a
8
Oct ’24
n/a
zł54.90
0%
21.0%
zł70.00
zł30.80
n/a
8
Sep ’24
n/a
zł55.20
0%
20.7%
zł70.00
zł30.80
zł102.71
8
Aug ’24
n/a
zł50.43
0%
22.6%
zł64.00
zł26.50
zł97.21
8
Jul ’24
n/a
zł48.40
0%
22.7%
zł64.00
zł26.50
zł103.29
8
Jun ’24
n/a
zł46.65
0%
20.1%
zł63.00
zł26.50
n/a
8
May ’24
n/a
zł46.68
0%
17.4%
zł63.00
zł29.50
n/a
9
Apr ’24
n/a
zł41.99
0%
13.2%
zł50.00
zł29.50
n/a
9
Mar ’24
n/a
zł40.15
0%
12.8%
zł48.20
zł29.80
n/a
9
Feb ’24
n/a
zł40.15
0%
12.8%
zł48.20
zł29.80
n/a
9
Jan ’24
n/a
zł39.75
0%
11.6%
zł44.89
zł29.80
n/a
9
Dec ’23
n/a
zł38.31
0%
14.4%
zł44.89
zł27.30
n/a
9
Nov ’23
n/a
zł36.33
0%
17.4%
zł44.89
zł26.70
n/a
9
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.